base metals investing Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery ) Development Candidates for the Treatment of Alzheimer's Disease
base metals investing Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
base metals investing Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference
base metals investing Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026
Syntholene Energy Corp. Appoints Former Suncor, Shell Operations Executive Marc Mageau to Advisory Board
Angkor Resources' Subsidiary Implements Playgrounds For Rural Schools In Block VIII Drilling Area, Cambodia
